Geneva Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Geneva Advisors's CME Position: Q2 2017 in Review
Geneva Advisors increased its CME Group (CME) stake by 273% in Q2 2017, buying an estimated $39.4M and bringing the position to 450,627 shares worth $56.4M. The position accounts for 0.97% of the portfolio, ranked #34.
Geneva Advisors first reported a position in CME in Q2 2013 and has held it in 17 quarters since. 772 funds tracked by Wall St. Rank hold CME as of Q2 2017.
- Geneva Advisors held 450,627 shares of CME Group worth $56.4M as of Q2 2017.
- Geneva Advisors bought 329,726 CME Group shares in Q2 2017, an estimated $39.4M.
- CME Group made up 0.97% of Geneva Advisors's portfolio in Q2 2017, its #34 holding.
- Geneva Advisors first reported a position in CME Group in Q2 2013 and has held it in 17 quarters since.
- 772 funds tracked by Wall St. Rank held CME Group as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.